PAG
FLXN

Private Advisor Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Private Advisor Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,007
Closed -$40K – 3801
2020
Q2 		$40K Buy
+3,007
New +$31.2K ﹤0.01% 2227

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Private Advisor Group's FLXN Position: Q3 2020 in Review

Private Advisor Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2020, closing a stake of 3,007 shares — an estimated $40K sold.

Private Advisor Group first reported a position in FLXN in Q2 2020 and held it in 1 quarter. The position peaked at $40K in Q2 2020. 135 funds tracked by Wall St. Rank hold FLXN as of Q3 2020.

  • Private Advisor Group reported no remaining Flexion Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 3,007 Flexion Therapeutics, Inc. shares in Q3 2020, an estimated $40K.
  • Private Advisor Group first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Flexion Therapeutics, Inc. position peaked at $40K in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.